| Q36025935 | Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2. |
| Q35041737 | Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes |
| Q38577514 | Aspirin dosing in cardiovascular disease prevention and management: an update |
| Q36409789 | Aspirin in dermatology: Revisited |
| Q34389630 | Aspirin resistance: Fact or fiction? A point of view |
| Q28217948 | Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease |
| Q84198992 | Can resistance to aspirin be reversed after an additional dose? |
| Q74463061 | Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils |
| Q61763071 | Complications of cirrhosis: is endothelium guilty? |
| Q28196435 | Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers |
| Q73871174 | Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway |
| Q28194199 | Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction |
| Q74243642 | Efficacy of leukocyte-depleted terminal blood cardioplegia in congenital heart disease |
| Q40023475 | Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha |
| Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
| Q35028995 | Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor |
| Q43788595 | Expression of an endothelial-type nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction |
| Q77896444 | Expression of inducible nitric oxide synthase in the carotid of rats after endothelial skinning: the effects of platelets and treatment with abciximab |
| Q35044172 | Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes |
| Q28194041 | Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine |
| Q42479093 | Influence of treatment with ultralow-dose aspirin on platelet aggregation as measured by whole blood impedance aggregometry and platelet P-selectin expression in clinically normal dogs |
| Q40572565 | Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer. |
| Q43899359 | Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms. |
| Q37772417 | Old and new molecular mechanisms associated with platelet resistance to antithrombotics |
| Q41290150 | Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism |
| Q35077628 | Platelet content of nitric oxide synthase 3 phosphorylated at Serine 1177 is associated with the functional response of platelets to aspirin. |
| Q51364946 | Potential role for ET-2 acting through ETA receptors in experimental colitis in mice. |
| Q28194671 | Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils |
| Q46541835 | Protective Effect of L-Arginine in Experimentally Induced Myocardial Ischemia: Comparison With Aspirin |
| Q28211835 | Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids |
| Q28196501 | Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases |
| Q71690209 | Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits |
| Q77682087 | Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects |
| Q61771952 | The HERACLES Cardiovascular Network |
| Q24794673 | The antithrombotic profile of aspirin. Aspirin resistance, or simply failure? |
| Q51665071 | The changes of plasma endothelin in oleic acid-induced acute lung injury and their implication. |
| Q35802504 | The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils |
| Q45998313 | The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. |
| Q40261478 | The endothelin B receptor plays a crucial role in the adhesion of neutrophils to the endothelium in sickle cell disease |
| Q55026371 | The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization. |
| Q43115813 | Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus. |
| Q46385770 | Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid |
| Q28194577 | What is the place of aspirin in venous thrombosis prophylaxis? |
| Q54055645 | [Aspirin and hemostasis]. |
| Q73660385 | [Effect of losartan on human platelet activation by thromboxane A2] |
| Q73587535 | [The effect of triflusal on human platelet aggregation and secretion: the role of nitric oxide] |
| Q74521063 | [Thrombosis and coronary disease: neutrophils, nitric oxide and aspirin] |